Iterum Therapeutics plc — Quarterly Financial Statistics (NASDAQ:ITRM)

Financials

Cash from operating activities 2.67 M4.26 M3.06 M4.75 M7.45 M 19.51 M Cash from investing activities 5.7 M1.1 M2 000012 K 1.11 M Cash from financing activities 5.43 M13.88 M8.39 M-5.12 M-1.1 M 16.04 M Free cash flow 2.67 M4.26 M3.06 M4.75 M7.43 M 19.5 M

新闻

Iterum Therapeutics扩大ORLYNVAH的医疗保险D部分覆盖范围

Iterum Therapeutics expands Medicare Part D access for ORLYNVAH

Iterum Therapeutics expands market access for ORLYNVAH antibiotic

Iterum Therapeutics为抗生素敲定重要PBM协议

Iterum Therapeutics secures major PBM agreement for antibiotic

Iterum Therapeutics收到纳斯达克关于上市合规的通知

Iterum Therapeutics receives Nasdaq notice on listing compliance

Iterum Therapeutics扩大ORLYNVAH的报销覆盖范围

Iterum Therapeutics expands reimbursement coverage for ORLYNVAH

Iterum’s antibiotic ORLYNVAH now available through McKesson

Iterum Therapeutics董事Dunne购入价值2,191美元的股份

Iterum Therapeutics director Dunne buys $2,191 in shares